Delivery Order SPE2DX22D0010-SPE2D826FCE98
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Metadate CD Caps 20mg, a medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order has a ceiling value of $7,322.65 with an ultimate completion date of April 25, 2025. The contract utilizes no set-aside designation and will be fulfilled from AmerisourceBergen's Corporate Office...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,666.38 to AmerisourceBergen Drug Corp for Metadate CD Caps 30mg, a methylphenidate extended-release medication used to treat attention deficit hyperactivity disorder. This firm fixed-price, competitively awarded contract was issued on November 3, 2025, with an ultimate completion date of November 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Metadate CD Caps 20mg, a methylphenidate-based medication used for attention deficit hyperactivity disorder treatment. This non-set-aside, competitively awarded contract is valued at $5,541.86 with a firm fixed price structure and an ultimate completion date of August 27, 2025. The order was executed on August 26, 2025, with performance taking place at...
- The Defense Department's Medical Supply Chain awarded a $2,879.62 delivery order to AmerisourceBergen Drug Corp for Metadate CD Caps 10mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. The award, issued on January 2, 2026, with an ultimate completion date of January 5, 2026, was made on a firm fixed-price basis without set-aside designation, indicating competitive award to this established federal pharmaceutical vendor....
- The U.S. Defense Department's Medical Supply Chain awarded a $2,198.83 delivery order to AmerisourceBergen Drug Corp for Metadate CD Caps 30mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order, issued on October 23, 2025, has an ultimate completion date of October 24, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The...
- The U.S. Department of Defense's Medical Supply Chain awarded a $1,516.09 delivery order to AmerisourceBergen Drug Corp for Metadate CD Caps 20mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on June 27, 2025, with an ultimate completion date of June 30, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 6, 2025, for the supply of Metadate CD Caps 10mg, a medication used to treat attention-deficit/hyperactivity disorder. This is a firm fixed-price delivery order with a ceiling value of $3,203.63 and an ultimate completion date of October 7, 2025. The award is unclassified as a set-aside contract, indicating it was competitively awarded. The place of performance is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Metadate CD Caps 20mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,006.19 and an ultimate completion date of August 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Metadate CD Caps 30mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This firm fixed price delivery order, valued at $8,397.85 with a completion deadline of August 26, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,784.33 delivery order to AmerisourceBergen Drug Corp for Metadate CD Caps 30mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This competitive award, issued on May 30, 2025, represents a firm fixed-price delivery order with a completion deadline of June 2, 2025. The contract carries no small business set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCE98Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $6,652.11 delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 6, 2026, for the supply of Metadate CD Caps 50mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This firm fixed-price, non-set-aside contract is scheduled for completion by January 7, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under Amerisourcebergen's larger pharmaceutical supply relationship with the federal government. This delivery order falls under Amerisourcebergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent company, Cencora, Inc., holds an even larger IDC with DLA valued at up to $999,999,999.00 through December 2031, which serves as a comprehensive global pharmaceutical support vehicle supplying medications, vaccines, medical devices, and specialized healthcare commodities to military treatment facilities and other federal medical institutions worldwide. These contracts demonstrate the contractor's established capability to efficiently fulfill critical pharmaceutical procurement needs for military and veteran healthcare systems through competitive, firm fixed-price arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 1/5/26 |